| Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy in primary mediastinal large B-cell lymphoma: the emerging standard of care TP Vassilakopoulos, GA Pangalis, A Katsigiannis, SG Papageorgiou, ... The oncologist 17 (2), 239, 2012 | 135 | 2012 |
| PET/CT in primary mediastinal large B-cell lymphoma responding to rituximab-CHOP: An analysis of 106 patients regarding prognostic significance and implications for subsequent … TP Vassilakopoulos, GA Pangalis, S Chatziioannou, S Papageorgiou, ... Leukemia 30 (1), 238-242, 2016 | 52 | 2016 |
| Rituximab-CHOP (R-CHOP) and Radiotherapy (RT) for Primary Mediastinal Large B-Cell Lymphoma (PMLBCL). TP Vassilakopoulos, MK Angelopoulou, Z Galani, S Sachanas, ... Blood, The Journal of the American Society of Hematology 108 (11), 2745-2745, 2006 | 11 | 2006 |
| B-microglobulin in Hodgkin's lymphoma: prognostic significance in patients treated with ABVD or equivalent regimens TP Vassilakopoulos, G Nadali, MK Angelopoulou, MN Dimopoulou, ... Journal of BUON 10, 59-69, 2005 | 8 | 2005 |
| Extramedullary sudden blast crisis in chronic-phase chronic myeloid leukemia during first-line treatment with nilotinib MK Angelopoulou, JV Asimakopoulos, Z Galani, G Levidou, M Roumelioti, ... Blood cancer journal 6 (8), e461-e461, 2016 | 7 | 2016 |
| Hepatic and renal plasma cell lesions in a patient with multiple myeloma in hematological remission Z Galani, N Viniou, MC Kyrtsonis, S Sachanas, T Antoniou, ... Anticancer research 27 (1B), 571-574, 2007 | 6 | 2007 |
| Outcome and prognostic factors in patients with Hodgkin lymphoma (HL) who remain PET/CT-positive after ABVD combination chemotherapy: potential applications for the design of … T Vassilakopoulos, P Rontogianni, G Pangalis, G Boutsikas, ... Haematologica 97, 562-562, 2012 | 5 | 2012 |
| Prognostic factors in patients with Hodgkin lymphoma (HL) and a negative PET/CT after ABVD chemotherapy: potential applications for the design of follow-up strategies T Vassilakopoulos, G Pangalis, G Boutsikas, P Rontogianni, S Masouridis, ... Haematologica 97, 87-88, 2012 | 5 | 2012 |
| Clinical implications and prognostic significance of positron emission tomography (PET/CT) in patients with diffuse large B-cell lymphoma (DLBCL) after R-CHOP chemoimmunotherapy TP Vassilakopoulos, A Kanellopoulos, S Papageorgiou, GA Pangalis, ... Haematologica 99, 702-702, 2014 | 3 | 2014 |
| The role of PET/CT after rituximab-CHOP (R-CHOP) in primary mediastinal large B-cell lymphoma (PMLBCL): response assessment, prognostic significance and implications for … T Vassilakopoulos, M Angelopoulou, P Rontogianni, S Masouridis, ... Haematologica 98, 135-135, 2013 | 3 | 2013 |
| Study of bone metabolism and angiogenesis in patients undergoing high‐dose chemotherapy/autologous hematopoietic stem cell transplantation G Boutsikas, E Terpos, A Papatheodorou, P Tsirkinidis, P Tsirigotis, ... European journal of haematology 100 (2), 131-139, 2018 | 2 | 2018 |
| Protein Z (PZ) and plasminogen activator inhibitor-1 (PAI-1) plasma levels in patients with previously untreated Hodgkin lymphoma (HL). G Boutsikas, E Terpos, A Markopoulos, A Papatheodorou, A Stefanou, ... Journal of BU ON.: official journal of the Balkan Union of Oncology 22 (4 …, 2017 | 2 | 2017 |
| THE PROGNOSTIC SIGNIFICANCE OF PET SCAN BEFORE AND AFTER HIGH-DOSE THERAPY AND AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT) IN RELAPSED/REFRACTORY HODGKIN LYMPHOMA (HL) PATIENTS M Angelopoulou, M Moschogiannis, P Rondogianni, V Pappis, ... Haematologica 97, 178-179, 2012 | 2 | 2012 |
| High-dose therapy and autologous stem cell transplantation (HDT/ASCT) in relapsed/refractory Hodgkin's lymphoma. Outcome and prognostic factors MK Angelopoulou, TP Vassilakopoulos, P Tsirkinidis, O Tsopra, Z Galani, ... BONE MARROW TRANSPLANTATION 45, S255-S255, 2010 | 2 | 2010 |
| Salvage treatment of patients with relapsed/refractory Hodgkin lymphoma with brentuximab vedotin: the Greek experience P Tsirigotis, T Vassilakopoulos, Z Bousiou, I Mpatsis, K Gkirkas, I Sakellari, ... Haematologica 100, 454-455, 2015 | 1 | 2015 |
| Bone as a regulator of human hematopoietic stem cell (HSC) trafficking: Study of biochemical markers of bone remodeling and angiogenic cytokines during HSC mobilization, in … P Tsirkinidis, E Terpos, G Boutsikas, A Papatheo-Dorou, K Anargyrou, ... BONE MARROW TRANSPLANTATION 50, S48-S49, 2015 | 1 | 2015 |
| Preemptive use of plerixafor in patients with lymphopro-liferative diseases undergoing haematopoietic stem cell mobilization: P527 V Telonis, T Vassilakopoulos, E Lalou, G Boutsikas, Z Galani, ... Bone Marrow Transplantation 48, 2013 | 1 | 2013 |
| ESHAP VS IGEV AS SALVAGE AND MOBILIZING REGIMENS IN RELAPSED OR REFRACTORY HODGKIN LYMPHOMA (HL) P Tsirkinidis, T Vassilakopoulos, O Tsopra, V Pappis, M Moschoyianni, ... HAEMATOLOGICA-THE HEMATOLOGY JOURNAL 95, 368-368, 2010 | 1 | 2010 |
| Parameters predicting for successful mobilization and collection of peripheral blood stem cells in patients with haematologic malignacies. A study of 209 patients MK Angelopoulou, TP Vassilakopoulos, O Tsopra, V Pappi, S Masouridis, ... BONE MARROW TRANSPLANTATION 45, S159-S160, 2010 | 1 | 2010 |
| Nodal peripheral T-cell lymphomas: Treatment outcome and prognostic factors MK Angelopoulou, TP Vassilakopoulos, P Tsirkinidis, S Masouridi, ... HAEMATOLOGICA-THE HEMATOLOGY JOURNAL 93, 310-310, 2008 | 1 | 2008 |
